World's top Pharmaceuticals stocks
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LLYEli Lilly and Co | $722.31bn | 68.57 | 0.62% |
NOVO BNovo Nordisk A/S | DKK3.90tn | 44.36 | 1.06% |
JNJ WDJohnson & Johnson | $397.54bn | 20.6 | 2.81% |
JNJJohnson & Johnson | $360.79bn | 16.07 | 3.18% |
MRKMerck & Co | $329.42bn | 56.6 | 2.31% |
ABBVAbbvie | $283.86bn | 31.76 | 3.73% |
AZNAstraZeneca | £191.76bn | 49.53 | 1.87% |
NOVNNovartis AG | CH₣180.62bn | 17.79 | 3.85% |
ROGRoche Holding AG | CH₣179.46bn | 12.51 | 4.26% |
RORoche Holding AG | CH₣179.46bn | 13.71 | 3.89% |
AMGNAmgen | $166.38bn | 44.05 | 2.79% |
PFEPfizer | $158.72bn | 9.98 | 5.89% |
SANSanofi SA | €118.04bn | 17.85 | 3.99% |
GSKGSK | £74.59bn | 14.25 | 3.28% |
CELG RTBristol-Myers Squibb Co | $91.10bn | 0.01 | 4610.69% |
BMYBristol-Myers Squibb Co | $91.10bn | 11.98 | 5.14% |
CSLCSL | AU$134.87bn | 34.9 | 1.39% |
GILDGilead Sciences | $82.18bn | 11.75 | 4.58% |
ZTSZoetis | $77.13bn | 32.26 | 0.92% |
MRKMerck KGaA | €67.61bn | 20.27 | 1.41% |